---
$id: https://graph.org.ai/products/commodity/51362204
$type: Product
source: UNSPSC
code: "51362204"
title: "Hexapropymate"
class: "51362200"
classTitle: "Hypnotic carboxylic acids"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hexapropymate

**UNSPSC Code**: 51362204
**Class**: [Hypnotic carboxylic acids](Hypnotic carboxylic acids.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a sedative and hypnotic with the molecular formula C10H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0J9RN2PRJ7, chemically known as cyclohexanol, 1-(2-propynyl)-, carbamate but generally known as hexapropymate, which bears US NIH Compound Identifier 9661. European Medicines Agency schedules Hexapropymate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08032MIG. The term HEXAPROPYMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules hexapropymate in its Anatomical Therapeutic Chemical (ATC) Classification. HEXAPROPYMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hexapropymate under HS 29242995 and SITC 51479. As of Q4 2014, HEXAPROPYMATE remains the US FDA Preferred Term for this commodity. Hexapropymate bears US NLM identifiers UMLS ID C0062664 and NCI Concept Code C83752. SMILES: C#CCC1(CCCCC1)OC(=O)N.

